Truist Securities cuts Ideaya Biosciences target price to $57 from $59
IDYA•Truist Securities cut its target price for Ideaya Biosciences to $57 from $59.
Related News
Incyte target price cut to $150 from $154 by Leerink Partners
INCY•
Nucor Corporation: KeyBanc raises target price to $301 from $286
NUE•
Gartner: Jefferies raises target price to $197 from $190
IT•
Upstart Holdings: Piper Sandler cuts target price to $35 from $51
UPST•
Sotera Health Company: Piper Sandler cuts target price to $24 from $25
SHC•